Marshall R. Posner | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Genomic and immune profiling of rare non-squamous sinonasal tumors. (journal article) Steuer, Conor Ernst \| Lubin, Daniel \| Adeyelu, Tolulope Tosin \| Bates, James Edward \| Shin, Dong Moon \| Patel, Mihir R. \| Schmitt, Nicole C. \| Stokes, William A. \| Bracken-Clarke, Dara Mark \| Abdulla, Farah R. \| ... \| Saba, Nabil F. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e18008-e18008 (2024). 10.1200/JCO.2024.42.16_suppl.e18008 Cite \| Source
TTMV and association with relapse in patients with HPV related SCCHN undergoing CRT. (journal article) Misiukiewicz, Krzysztof \| Ramos, Emily J \| Worona, Leslie Anne \| Sindhu, Kunal K. \| Bakst, Richard Lorne \| Roof, Scott \| Genden, Eric Michael \| Westra, William \| Posner, Marshall R. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 6067-6067 (2024). 10.1200/JCO.2024.42.16_suppl.6067 Cite \| Source
Can TTMV clearance predict recurrence in HPV HNSCC? (journal article) Misiukiewicz, Krzysztof \| Worona, Leslie Anne \| Ramos, Emily J \| Bakst, Richard Lorne \| Sindhu, Kunal K. \| Westra, William \| Roof, Scott \| Genden, Eric Michael \| Posner, Marshall R. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 6066-6066 (2024). 10.1200/JCO.2024.42.16_suppl.6066 Cite \| Source
Clinical, molecular, and immunologic profiling of brain metastases (BM) in head and neck squamous cell carcinoma (HNSCC). (journal article) Dennis, Michael J. \| Pavlick, Dean \| Kacew, Alec \| Wotman, Michael \| MacConaill, Laura E \| Jones, Stephanie M \| Pfaff, Kathleen L. \| Rodig, Scott J. \| Reister, Emily \| Malig, Maika \| ... \| Hanna, Glenn J. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 6036-6036 (2024). 10.1200/JCO.2024.42.16_suppl.6036 Cite \| Source
Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study (journal article) Barlow, Joshua \| Gilja, Shivee \| Ferrandino, Rocco M. \| Berger, Michael H. \| Posner, Marshall R. \| Bakst, Richard L. \| Khan, Mohemmed N. \| Teng, Marita S. \| Genden, Eric M. \| Chai, Raymond L. \| Roof, Scott A. American Journal of Otolaryngology, volume 45, issue 3, pages 104243- (2024). 10.1016/j.amjoto.2024.104243 Cited by (1) \| Cite \| Source
Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell Carcinoma (journal article) Hsieh, Kristin \| Hotca, Alexandra Elena \| Dickstein, Daniel R. \| Lehrer, Eric J. \| Hsieh, Celina \| Gupta, Vishal \| Sindhu, Kunal K. \| Liu, Jerry T. \| Reed, Samuel H. \| Chhabra, Arpit \| ... \| Bakst, Richard L. Advances in Radiation Oncology, volume 9, issue 4, pages 101418- (2024). 10.1016/j.adro.2023.101418 Cite \| Source
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic (journal article) Bloom, Julie R. \| Rodriguez-Russo, Carlos \| Hsieh, Kristin \| Dickstein, Daniel R. \| Sheu, Ren-Dih \| Jain, Mayuri \| Moshier, Erin \| Liu, Jerry \| Gupta, Vishal \| Kirke, Diana N. \| ... \| Sharma, Sonam Current Oncology, volume 31, issue 1, pages 436-446 (2024). 10.3390/curroncol31010029 Cite \| Source
Liquid Biopsies for Head and Neck Cancers—Any Hope for Human Papillomavirus–Negative Disease?—Reply (journal article) Ferrandino, Rocco M. \| Posner, Marshall R. \| Roof, Scott A. JAMA Otolaryngology–Head & Neck Surgery, volume 150, issue 1, pages 83- (2024). 10.1001/jamaoto.2023.3633 Cite \| Source
Circulating Tumor HPV DNA in Patients With Head and Neck Carcinoma (journal article) Mijares, Kevin \| Ferrandino, Rocco \| Chai, Raymond \| Roof, Scott \| Bhardwaj, Swati \| Posner, Marshall \| Westra, William H. American Journal of Surgical Pathology, volume 48, issue 1, pages 80-87 (2024). 10.1097/PAS.0000000000002134 Cited by (1) \| Cite \| Source
Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer (journal article) Ferrandino, Rocco M. \| Chen, Sida \| Kappauf, Catharine \| Barlow, Joshua \| Gold, Brandon S. \| Berger, Michael H. \| Westra, William H. \| Teng, Marita S. \| Khan, Mohemmed N. \| Posner, Marshall R. \| ... \| Roof, Scott A. JAMA Otolaryngology–Head & Neck Surgery, volume 149, issue 11, pages 971- (2023). 10.1001/jamaoto.2023.1937 Cited by (16) \| Cite \| Source
Early detection of recurrent HPV+ hypopharyngeal squamous cell carcinoma by circulating tumor DNA (journal article) Kao, Derek D. \| Posner, Marshall R. \| Roof, Scott A. Otolaryngology Case Reports, volume 27 (2023). 10.1016/j.xocr.2023.100537 Cite \| Source
Clinical validity of TTMV-HPV DNA liquid biopsies for the diagnosis and surveillance of HPV-associated oropharyngeal carcinoma. (journal article) Roof, Scott A. \| Ferrandino, Rocco \| Chen, Sida \| Kappauf, Catharine \| Barlow, Joshua \| Gold, Brandon \| Westra, William \| Berger, Michael \| Teng, Marita S \| Khan, Mohemmed N \| ... \| Misiukiewicz, Krzysztof Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 6060-6060 (2023). 10.1200/JCO.2023.41.16_suppl.6060 Cite \| Source
Association of HPV genotype and phylogenic clade with oropharyngeal cancer outcomes. (journal article) Wotman, Michael \| Gold, Brandon \| D'Andrea, Megan \| Kao, Derek \| Westra, William \| Roof, Scott \| Misiukiewicz, Krzystof \| Posner, Marshall R. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 6058-6058 (2023). 10.1200/JCO.2023.41.16_suppl.6058 Cite \| Source
The Quarterback trials: A phase 2 series of sequential studies of induction chemotherapy followed by reduced dose chemoradiation for human papillomavirus positive oropharynx cancer. (journal article) Posner, Marshall R. \| Botzler, John \| Takahashi, Mai \| Roof, Scott \| Genden, Eric Michael \| Miles, Brett \| Bakst, Richard Lorne \| Moshier, Erin \| Gupta, Vishal \| Sharma, Sonam \| Misiukiewicz, Krzystof Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 6020-6020 (2023). 10.1200/JCO.2023.41.16_suppl.6020 Cited by (1) \| Cite \| Source
Nominating molecular/immunologic drivers of central nervous system (CNS) metastases in squamous cell carcinoma of the head/neck (SCCHN). (journal article) Kacew, Alec \| Wotman, Michael \| Quinn, Charles T \| MacConaill, Laura E \| Egloff, Ann Marie \| Jones, Stephanie M \| Pfaff, Kathleen L. \| Rodig, Scott J. \| Sehgal, Kartik \| Haddad, Robert I. \| ... \| Hanna, Glenn J. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e18002-e18002 (2023). 10.1200/JCO.2023.41.16_suppl.e18002 Cite \| Source
Are we ready for biomarker driven, radiation dose–adaptable de-escalation studies for HPV+ oropharyngeal cancer? (journal article) Misiukiewicz, Krzysztof \| Worona, Leslie \| Ramos, Emily J \| Bakst, Richard Lorne \| Sindhu, Kunal K. \| Westra, Wiliam J \| Roof, Scott \| Posner, Marshall R. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 6084-6084 (2023). 10.1200/JCO.2023.41.16_suppl.6084 Cite \| Source
Combination Immunotherapy in Head and Neck Cancer—Checkmate or a Draw? (journal article) Posner, Marshall JAMA Oncology, volume 9, issue 6, pages 789- (2023). 10.1001/jamaoncol.2023.0086 Cited by (1) \| Cite \| Source
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral Tongue (journal article) Jones, Brianna M. \| Villavisanis, Dillan F. \| Lehrer, Eric J. \| Dickstein, Daniel R. \| Sindhu, Kunal K. \| Misiukiewicz, Krzysztof J. \| Posner, Marshall \| Liu, Jerry T. \| Gupta, Vishal \| Sharma, Sonam \| ... \| Bakst, Richard L. The Laryngoscope, volume 133, issue 5, pages 1110-1121 (2023). 10.1002/lary.30253 Cited by (2) \| Cite \| Source
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma (journal article) Berger, Barry M. \| Hanna, Glenn J. \| Posner, Marshall R. \| Genden, Eric M. \| Lautersztain, Julio \| Naber, Stephen P. \| Del Vecchio Fitz, Catherine \| Kuperwasser, Charlotte Clinical Cancer Research, volume 28, issue 19, pages 4292-4301 (2022). 10.1158/1078-0432.CCR-22-0562 Cited by (50) \| Cite \| Source
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) – study protocol for a phase II non-randomized non-inferiority trial (journal article) Chai, Raymond L. \| Ferrandino, Rocco M. \| Barron, Christine \| Donboli, Kianoush \| Roof, Scott A. \| Khan, Mohemmed N. \| Teng, Marita S. \| Posner, Marshall R. \| Bakst, Richard L. \| Genden, Eric M. Frontiers in Oncology, volume 12 (2022). 10.3389/fonc.2022.965578 Cited by (6) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
Cancer Clinical Investigation	Posner, Marshall R	2020	$26,344	NATIONAL CANCER INSTITUTE
Developing a Therapeutics Platform for Adenoid Cystic Carcinoma	Posner, Marshall R	2020	$254,250	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
Clinical Protocol and Data Management/Clinical Trials Office (Core-007)	Posner, Marshall R	2019	$149,265	NATIONAL CANCER INSTITUTE
Clinical Protocol and Data Management/Clinical Trials Office (Core-007)	Posner, Marshall R	2018	$164,991	NATIONAL CANCER INSTITUTE
Clinical Protocol and Data Management/Clinical Trials Office (Core-007)	Posner, Marshall R	2017	$164,991	NATIONAL CANCER INSTITUTE
Clinical Protocol and Data Management/Clinical Trials Office (Core-007)	Posner, Marshall R	2016	$164,990	NATIONAL CANCER INSTITUTE
Clinical Protocol and Data Management/Clinical Trials Office (Core-007)	Posner, Marshall R	2015	$101,344	NATIONAL CANCER INSTITUTE
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response	Posner, Marshall R	2009	$370,980	NATIONAL CANCER INSTITUTE
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response	Posner, Marshall R	2008	$388,730	NATIONAL CANCER INSTITUTE
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2008	$395,320	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2007	$170,000	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2007	$402,977	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2006	$411,595	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2005	$63,068	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Functional Mechanisms of Antibody Inhibition of HIV-1	Posner, Marshall R	2005	$357,383	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV	Posner, Marshall R	2003	$369,153	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV	Posner, Marshall R	2002	$358,401	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV	Posner, Marshall R	2001	$354,461	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV	Posner, Marshall R	2000	$366,395	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV 1	Posner, Marshall R	1998	$257,750	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV 1	Posner, Marshall R	1997	$253,381	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV 1	Posner, Marshall R	1996	$241,004	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV-1	Posner, Marshall R	1995	$209,992	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV-1	Posner, Marshall R	1994	$220,387	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV-1	Posner, Marshall R	1993	$211,121	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT LEUKEMIAS	Posner, Marshall R	1992	$198,219	NATIONAL CANCER INSTITUTE
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT LEUKEMIAS	Posner, Marshall R	1991	$197,024	NATIONAL CANCER INSTITUTE
HIV-1 INFECTION USING HUMAN MONOCLONAL ANTIBODIES	Posner, Marshall R	1990	$146,430	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HIV-1 INFECTION USING HUMAN MONOCLONAL ANTIBODIES	Posner, Marshall R	1990	$16,431	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT LEUKEMIAS	Posner, Marshall R	1990	$215,399	NATIONAL CANCER INSTITUTE
HIV-1 INFECTION USING HUMAN MONOCLONAL ANTIBODIES	Posner, Marshall R	1989	$0	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HIV-1 INFECTION USING HUMAN MONOCLONAL ANTIBODIES	Posner, Marshall R	1988	$155,166	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
HUMAN MYELOMA ANALOGUES FOR MAKING MONOCLONAL ANTIBODIES	Posner, Marshall R	1987	$75,402	NATIONAL CANCER INSTITUTE
HUMAN MYELOMA ANALOGUES FOR MAKING MONOCLONAL ANTIBODIES	Posner, Marshall R	1986	$80,851	NATIONAL CANCER INSTITUTE
HUMAN MYELOMA ANALOGUES FOR MAKING MONOCLONAL ANTIBODIES	Posner, Marshall R	1985	$77,776	NATIONAL CANCER INSTITUTE